What is it about?

To report a case of successful treatment of macrophage activation syndrome complicating adult-onset Still’s disease.

Featured Image

Why is it important?

Macrophage activation syndrome complicating adult-onset Still’s disease carries a high mortality and is often difficult to treat. We treated a patient successfully with a targeted biological agent tocilizumab after a non-selective suppression of the over-active immunity with high dose systemic steroid.

Perspectives

We also provide a pathophysiological rationale for this approach.

Dr Ho So
Kwong Wah Hospital

Read the Original

This page is a summary of: Successful treatment of macrophage activation syndrome complicating adult-onset Still’s disease with tocilizumab: a case report, Hong Kong Bulletin on Rheumatic Diseases, December 2017, De Gruyter,
DOI: 10.1515/hkbrd-2017-0011.
You can read the full text:

Read

Contributors

The following have contributed to this page